FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061200535> ?p ?o ?g. }

• W2061200535 endingPage "3036" @default.
• W2061200535 startingPage "3029" @default.
• W2061200535 abstract "Pseudomonas aeruginosa is a difficult-to-treat bacterial pathogen often isolated from patients with serious nosocomial infections. The goal of this analysis is to present the clinical and microbiologic effectiveness of doripenem in the treatment of infections due to P. aeruginosa.A meta-analysis was conducted on the subset of subjects enrolled in four randomized phase III clinical trials of doripenem in subjects with complicated intra-abdominal infections (cIAI) and nosocomial pneumonia/ventilator-associated pneumonia (NP/VAP) due to P. aeruginosa. Clinical and microbiologic success was determined by infection and across the two infections.Clinical success rates for modified intent-to-treat (mITT) subjects with P. aeruginosa in the cIAI and NP/VAP groups were 78.7% (37/47) and 59.6% (31/52), respectively, following treatment with doripenem versus 74.3% (26/35) and 32.8% (19/58), respectively, for subjects in the comparator groups (p < 0.05 for difference in success rates across infection types). Microbiologic eradication rates also favored doripenem, although the differences did not achieve statistical significance. The weighted difference (doripenem minus comparator) for the mITT population in clinical success rates between doripenem and the comparator agents was 16.0% (95% CI: 3.1%, 29.0%) and for microbiologic eradication rates was 9.1% (95% CI: -4.2%, 22.3%). The proportion of subjects reporting one or more treatment-emergent adverse events or serious adverse events was similar for doripenem and the comparator agents. Fourteen doripenem and 14 comparator subjects died during the study. Limitations of this retrospective meta-analysis also include the qualitative heterogeneity of the data, and a selected, narrow population of moderately ill clinical trial subjects included in the analysis. Due to limitations, these data may not be generalizable to all populations and should be considered hypothesis generating.The weighted difference in clinical success rates for subjects with cIAI and NP/VAP infections caused by P. aeruginosa was in favor of doripenem, with the relative benefit of doripenem compared with the comparator agents similar across the two infections." @default.
• W2061200535 created "2016-06-24" @default.
• W2061200535 creator A5005458541 @default.
• W2061200535 creator A5023581417 @default.
• W2061200535 creator A5057030697 @default.
• W2061200535 creator A5061666850 @default.
• W2061200535 creator A5069366221 @default.
• W2061200535 date "2009-10-23" @default.
• W2061200535 modified "2023-09-25" @default.
• W2061200535 title "Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials" @default.
• W2061200535 cites W1859978788 @default.
• W2061200535 cites W1907037236 @default.
• W2061200535 cites W1969145083 @default.
• W2061200535 cites W1970698892 @default.
• W2061200535 cites W2011858141 @default.
• W2061200535 cites W2011920054 @default.
• W2061200535 cites W2023992300 @default.
• W2061200535 cites W2024275624 @default.
• W2061200535 cites W2047179869 @default.
• W2061200535 cites W2050832572 @default.
• W2061200535 cites W2067647269 @default.
• W2061200535 cites W2097399590 @default.
• W2061200535 cites W2103780797 @default.
• W2061200535 cites W2115486016 @default.
• W2061200535 cites W2118975078 @default.
• W2061200535 cites W2131443556 @default.
• W2061200535 cites W2144178695 @default.
• W2061200535 cites W2148706534 @default.
• W2061200535 cites W2149198421 @default.
• W2061200535 cites W2162191692 @default.
• W2061200535 cites W2321428848 @default.
• W2061200535 doi "https://doi.org/10.1185/03007990903396790" @default.
• W2061200535 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19849650" @default.
• W2061200535 hasPublicationYear "2009" @default.
• W2061200535 type Work @default.
• W2061200535 sameAs 2061200535 @default.
• W2061200535 citedByCount "10" @default.
• W2061200535 countsByYear W20612005352014 @default.
• W2061200535 countsByYear W20612005352015 @default.
• W2061200535 countsByYear W20612005352016 @default.
• W2061200535 countsByYear W20612005352017 @default.
• W2061200535 countsByYear W20612005352018 @default.
• W2061200535 crossrefType "journal-article" @default.
• W2061200535 hasAuthorship W2061200535A5005458541 @default.
• W2061200535 hasAuthorship W2061200535A5023581417 @default.
• W2061200535 hasAuthorship W2061200535A5057030697 @default.
• W2061200535 hasAuthorship W2061200535A5061666850 @default.
• W2061200535 hasAuthorship W2061200535A5069366221 @default.
• W2061200535 hasConcept C126322002 @default.
• W2061200535 hasConcept C177713679 @default.
• W2061200535 hasConcept C197934379 @default.
• W2061200535 hasConcept C2777184939 @default.
• W2061200535 hasConcept C2777637488 @default.
• W2061200535 hasConcept C2777821550 @default.
• W2061200535 hasConcept C2777914695 @default.
• W2061200535 hasConcept C2779375183 @default.
• W2061200535 hasConcept C2908647359 @default.
• W2061200535 hasConcept C501593827 @default.
• W2061200535 hasConcept C523546767 @default.
• W2061200535 hasConcept C535046627 @default.
• W2061200535 hasConcept C54355233 @default.
• W2061200535 hasConcept C71924100 @default.
• W2061200535 hasConcept C86803240 @default.
• W2061200535 hasConcept C89423630 @default.
• W2061200535 hasConcept C94665300 @default.
• W2061200535 hasConcept C99454951 @default.
• W2061200535 hasConceptScore W2061200535C126322002 @default.
• W2061200535 hasConceptScore W2061200535C177713679 @default.
• W2061200535 hasConceptScore W2061200535C197934379 @default.
• W2061200535 hasConceptScore W2061200535C2777184939 @default.
• W2061200535 hasConceptScore W2061200535C2777637488 @default.
• W2061200535 hasConceptScore W2061200535C2777821550 @default.
• W2061200535 hasConceptScore W2061200535C2777914695 @default.
• W2061200535 hasConceptScore W2061200535C2779375183 @default.
• W2061200535 hasConceptScore W2061200535C2908647359 @default.
• W2061200535 hasConceptScore W2061200535C501593827 @default.
• W2061200535 hasConceptScore W2061200535C523546767 @default.
• W2061200535 hasConceptScore W2061200535C535046627 @default.
• W2061200535 hasConceptScore W2061200535C54355233 @default.
• W2061200535 hasConceptScore W2061200535C71924100 @default.
• W2061200535 hasConceptScore W2061200535C86803240 @default.
• W2061200535 hasConceptScore W2061200535C89423630 @default.
• W2061200535 hasConceptScore W2061200535C94665300 @default.
• W2061200535 hasConceptScore W2061200535C99454951 @default.
• W2061200535 hasIssue "12" @default.
• W2061200535 hasLocation W20612005351 @default.
• W2061200535 hasLocation W20612005352 @default.
• W2061200535 hasOpenAccess W2061200535 @default.
• W2061200535 hasPrimaryLocation W20612005351 @default.
• W2061200535 hasRelatedWork W1966940699 @default.
• W2061200535 hasRelatedWork W2016772536 @default.
• W2061200535 hasRelatedWork W2053207687 @default.
• W2061200535 hasRelatedWork W2157912098 @default.
• W2061200535 hasRelatedWork W2162207945 @default.
• W2061200535 hasRelatedWork W2172244517 @default.
• W2061200535 hasRelatedWork W2269344475 @default.
• W2061200535 hasRelatedWork W2963776042 @default.
• W2061200535 hasRelatedWork W2996565538 @default.

• next